13F Insight
DOSSIER · 13F-HR · Q2 2026

Lion Point Capital, LP

$21M in tracked AUM across 35 positions as of Q2 2026.

LP
CIK 0001643354 · last filed Jun 30, 2026
Total AUM
$21M
as of Q2 2026
Holdings
35
—
positions
Whale Score
51
51
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Lion Point Capital, LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
CUE
CUE BIOPHARMA INC
$2M53K8.0%02
PRAX
PRAXIS PRECISION MEDICINES I
$1M4K7.1%03
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
$1M68K6.3%04
FENC
FENNEC PHARMACEUTICALS INC
$1M112K5.8%05
G7709Q104
ROYALTY PHARMA PLC
$1M21K5.7%06
CMPS
COMPASS PATHWAYS PLC
$1M80K5.4%07
MIST
MILESTONE PHARMACEUTICALS IN
$1M820K5.3%08
BNTC
BENITEC BIOPHARMA INC
$830K62K4.0%09
SNDX
SYNDAX PHARMACEUTICALS INC
$787K36K3.8%10
G1110E107
BIOHAVEN LTD
$769K52K3.7%

Filing history

2026Q2Jun 30
$21M▲ 24.9%
35 positionsView →2026Q1Mar 31
$17M▼ 13.4%
35 positionsView →2025Q4Dec 31
$19M▲ 61.3%
39 positionsView →2025Q3Sep 30
$12M▼ 18.6%
20 positionsView →2025Q2Jun 30
$15M▲ 73.8%
19 positionsLocked2025Q1Mar 31
$8M▼ 55.6%
14 positionsLocked2024Q4Dec 31
$19M▼ 57.5%
19 positionsLocked2024Q3Sep 30
$45M▼ 18.1%
25 positionsLocked2024Q2Jun 30
$55M▼ 69.3%
27 positionsLocked2024Q1Mar 31
$179M▼ 10.5%
32 positionsLocked2023Q4Dec 31
$200M▼ 10.9%
30 positionsLocked2023Q3Sep 30
$224M▲ 1.4%
31 positionsLocked
Showing 12 of 39